| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |